Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-291-6 | CAS number: 56-84-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
L-aspartic acid is a naturally occurring amino acid and is practically non-toxic in the acute toxicity studies available.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2002
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study with GLP.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Strain: Crl:CD(SD)IGS BR.
Supplier: Charles River WIGA, Germany
Age: Ca. 8 weeks at the time of the administration.
Room temperature: Average of 22.1 °C.
Relative humidity: Average of 47.6 %.
Air exchange: 12 per hour.
Light: Artificial light from 6 a.m. to 6 p.m.
Cages: Single caging in Makrolon cages type III (39 cm x 23 cm bottom area, 18 cm height). Wire mesh lids.
Bedding material: Aspen wood chips, autoclaved.
Environmental enrichment: Nibbling wood bricks (10 cm x 2 cm x 2 cm) and nesting material.
Feed: Altromin 1324 forte, gamma irradiated with 25 kGy 60Co, ad libitum. Exception: The feed was withdrawn the evening before the administration of the test substance and was offered again about three hours afterwards.
Water: Tap water, ad libitum.
Acclimatisation: At least 5 days. - Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Details on oral exposure:
- The test substance was suspended in 0.1 % carboxymethyl cellulose, as an aqueous solution.
- Doses:
- 200 and 2000 mg/kg bw.
Dose volume: 10 mL/kg bw. - No. of animals per sex per dose:
- 3 m + 3 f per dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days.
- Frequency of observations and weighing: Observations were performed within the periods 0 - 0.5, 0.5 - 1, 1 - 2, 2 - 4 and 4 - 6 hours after administration (p.a.) of the test substance and then at least once a day. Body weights were determined before administration, 7 days p.a. and 14 days p.a.
- Necropsy of survivors performed: yes. - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality was observed.
- Clinical signs:
- other: No toxic effects were observed.
- Gross pathology:
- All animals were normal at the necropsy 14 d p.a.
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: OECD GHS
- Conclusions:
- No toxic effects of the test substance were noted by signs in life and post mortem. The oral LD50 of L-aspartic acid to rats was estimated to be higher than 2000 mg/kg body weight.
- Executive summary:
Methods and investigations were performed in conformance with the OECD-Guideline 423, 1996 and the Directive 96/54/EC, method B.1.tris. L-Aspartic acid was administered once by stomach intubation to 6 male and 6 female rats as a suspension in 0.1 % aqueous carboxymethyl cellulose. The dosing was performed sequentially to groups of 3 animals per sex using a starting dose of 200 mg per kg body weight and 2000 mg per kg body weight as the second dose.
No toxic effects of the test substance were noted by signs in life and post mortem. According to the decision trees of the guidelines the LD50,oral of L-aspartic acid was estimated to be higher than 2000 mg/kg body weight in rats.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Guideline study with GLP.
The LD50 in the key study is not 2000 mg/kg bw but greater than 2000 mg/kg bw. This result can not be entered in the preceding field.
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Data waiving:
- other justification
- Justification for data waiving:
- other:
Reference
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- other: Citation in a peer reviewed journal.
- Principles of method if other than guideline:
- Tada 2008 cited in his publication a study on the acute dermal toxicity with rabbits and the result of the study.
- Test type:
- standard acute method
- Species:
- rabbit
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- 5 000 mg/kg bw
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: OECD GHS
- Conclusions:
- The dermal LD50 of L-aspartic acid to rabbits is reported to be 5000 mg/kg bw.
- Executive summary:
Tada 2008 cited in his publication a study on the acute dermal toxicity with rabbits and the result of the study.
The dermal LD50 of L-aspartic acid to rabbits is reported to be 5000 mg/kg bw.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
- Quality of whole database:
- The weight of evidence, including a acute dermal toxicity study and acute toxicity studies with other routes and no local effects, is considered to be sufficient to conclude a low toxicity and no classification of L-aspartic acid after acute dermal dosing.
Additional information
The key study was chosen.
The result is supported by two further data: In the first cited study, the oral LD50 of L-aspartic acid to rats is 5 000 mg/kg bw.
In the second cited study, the oral LD50 of L-aspartic acid to rats is greater than 16 000 mg/kg bw.
Justification for selection of acute toxicity – inhalation endpoint
According to column 2 of Annex VIII of REACH, i.e. "Testing by the inhalation route is appropriate if exposure of humans via inhalation is likely taking into account the vapour pressure of the substance and/or the possibility of exposure to aerosols, particles or droplets of an inhalable size." The high mass median diameter of the substance is between 372 and 401 µm. The low vapour pressure is 0.000035 Pa at 25 °C. No relevant exposure of humans is therefore expected and no justification to perform an acute inhalation toxicity test is obtained.
In addition, L-aspartic acid is not classified as to local irritation and does not show toxic effect in the acute toxicity studies with oral, dermal and intraperitoneal routes of administration, even at high doses of 5000 mg/kg bw and above. Therefore and with respect to animal welfare an acute inhalation toxicity study is not justified.
Justification for selection of acute toxicity – dermal endpoint
The substance is not classified as to local irritation and does not show toxic effect in the acute toxicity studies with oral, dermal and intraperitoneal route of administration even at high doses of 5000 mg/kg bw and above. Therefore and with respect to animal welfare, the repetition of the acute dermal toxicity study, which is not described to present standards, is not justified.
Justification for classification or non-classification
There is no indication from the various studies with different routes of application that a classification might be required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.